Cargando…
In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases
How metastases develop is not well understood and no genetic mutations have been reported as specific metastatic drivers. Here we have addressed the idea that epigenetic reprogramming by GLI-regulated pluripotent stemness factors promotes metastases. Using primary human colon cancer cells engrafted...
Autores principales: | Singovski, Grigori, Bernal, Carolina, Kuciak, Monika, Siegl-Cachedenier, Irene, Conod, Arwen, Ruiz i Altaba, Ariel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816146/ https://www.ncbi.nlm.nih.gov/pubmed/26031752 http://dx.doi.org/10.1093/jmcb/mjv034 |
Ejemplares similares
-
Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells
por: Seth, Chandan, et al.
Publicado: (2016) -
Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas
por: Varnat, Frédéric, et al.
Publicado: (2010) -
A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
por: Duquet, Arnaud, et al.
Publicado: (2014) -
Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner
por: Kuciak, Monika, et al.
Publicado: (2019) -
The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
por: Mishra, Sonakshi, et al.
Publicado: (2019)